Cochlear Ltd, the Australian global pioneer for implantable hearing solutions, with the view of direct marketing in India has opened offices in Mumbai, New Delhi and Bangalore, seeing the huge potential for its product base in the Indian healthcare market.
Cochlear Ltd, has been in the Indian market for almost 15 years through distribution tie ups and will invest $15 million over a period of five years to spread product awareness and hearing impairment through educational camps and campaigning among physicians.
The company plans to initially set up 45 cochlear implant clinics all over India and later increase market presence by having leading surgeons in the field offering the treatment.
Dyranda Hortle, regional director- Southern Asia, Cochlear Ltd, said, "We have identified that the biggest challenge for us in India is the lack of awareness among parents about the importance of the disease in this area and the need of cochlear implants. We are also ready to work with the government championing early intervention in children,". She also pointed out that the products are offered in India for almost half the price of which it is available in Australia, giving special consideration to affordability issues of treatment here.
WHO estimates state that 63 million people suffer from significant auditory impairment in India.
Cochlear Medical Devices India Pvt Ltd, will be marketing three types of implantable technologies namely the Baha bone conduction implants which uses a Swedish technology for adults and children with outer and middle ear problems and total deafness in one ear, Cochlear Hybrid electroacoustic implants offering a unique combination of cochlear implant and a hearing aid, and Cochlear Nucleus 5 a most advanced and slimmer hearing solution for adults and children with moderate to profound hearing loss.
Visit the Cochlear Ltd website for more information.